The efficacy and safety of endostar combined with taxane-based regimens for HER-2-negative metastatic breast cancer patients

The purpose of the present study was to prospectively evaluate the efficacy and safety of endostar, a recombinant product of endostatin, combined with taxane-based regimens for HER-2 negative metastatic breast cancer (MBC) patients. Women with ages between 18–70 years with histologically confirmed M...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Weiwei, Liu, Jian, Wu, Fan, Chen, Kan, Li, Nani, Hong, Yi, Huang, Cheng, Zhen, Hongyu, Lin, Lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5058773/
https://www.ncbi.nlm.nih.gov/pubmed/27129172
http://dx.doi.org/10.18632/oncotarget.8967

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5058773/
https://www.ncbi.nlm.nih.gov/pubmed/27129172
http://dx.doi.org/10.18632/oncotarget.8967

Ejemplares similares